MoneyWorks4Me

Zydus Lifesciences informs about press release

28 May 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated May 28, 2025, titled ‘Zydus receives USFDA ‘Fast Track Designation’ for Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of Amyotrophic Lateral Sclerosis (ALS)’. The contents of the press release give full details. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..